HRTX vs. NVDA
Compare and contrast key facts about Heron Therapeutics, Inc. (HRTX) and NVIDIA Corporation (NVDA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: HRTX or NVDA.
Correlation
The correlation between HRTX and NVDA is 0.60, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
HRTX vs. NVDA - Performance Comparison
Loading data...
Key characteristics
HRTX:
145.66%
NVDA:
59.43%
HRTX:
-12.81%
NVDA:
-89.73%
HRTX:
-12.81%
NVDA:
-21.93%
Fundamentals
HRTX:
$321.91M
NVDA:
$2.85T
HRTX:
-$0.05
NVDA:
$2.94
HRTX:
-0.18
NVDA:
1.66
HRTX:
2.17
NVDA:
21.81
HRTX:
12.60
NVDA:
36.01
HRTX:
$157.98M
NVDA:
$104.45B
HRTX:
$109.86M
NVDA:
$77.45B
HRTX:
-$1.53M
NVDA:
$68.38B
Returns By Period
HRTX
N/A
N/A
N/A
N/A
N/A
N/A
NVDA
-13.13%
5.16%
-20.97%
29.82%
72.26%
72.36%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
HRTX vs. NVDA — Risk-Adjusted Performance Rank
HRTX
NVDA
HRTX vs. NVDA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Heron Therapeutics, Inc. (HRTX) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
HRTX vs. NVDA - Dividend Comparison
HRTX has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.03%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
HRTX Heron Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.03% | 0.02% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% | 1.70% |
Drawdowns
HRTX vs. NVDA - Drawdown Comparison
The maximum HRTX drawdown since its inception was -12.81%, smaller than the maximum NVDA drawdown of -89.73%. Use the drawdown chart below to compare losses from any high point for HRTX and NVDA. For additional features, visit the drawdowns tool.
Loading data...
Volatility
HRTX vs. NVDA - Volatility Comparison
Loading data...
Financials
HRTX vs. NVDA - Financials Comparison
This section allows you to compare key financial metrics between Heron Therapeutics, Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
HRTX vs. NVDA - Profitability Comparison
HRTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Heron Therapeutics, Inc. reported a gross profit of 30.45M and revenue of 38.90M. Therefore, the gross margin over that period was 78.3%.
NVDA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, NVIDIA Corporation reported a gross profit of 28.72B and revenue of 39.33B. Therefore, the gross margin over that period was 73.0%.
HRTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Heron Therapeutics, Inc. reported an operating income of 3.15M and revenue of 38.90M, resulting in an operating margin of 8.1%.
NVDA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, NVIDIA Corporation reported an operating income of 24.03B and revenue of 39.33B, resulting in an operating margin of 61.1%.
HRTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Heron Therapeutics, Inc. reported a net income of 2.64M and revenue of 38.90M, resulting in a net margin of 6.8%.
NVDA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, NVIDIA Corporation reported a net income of 22.09B and revenue of 39.33B, resulting in a net margin of 56.2%.